Drawing for CHEWMED

USPTO serial 87657190

CHEWMED

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
RHIM, ANDREW
Law office
TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CHEWMED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles P. Guarino

CHARLES P. GUARINO MOSER TABOADA1030 BROAD STREETSUITE 203SHREWSBURY, NJ 07702

Goods and services

ClassDescriptionStatusFirst use
005nutritional supplementsABANDONED—
040Custom manufacture of nutritional supplements for othersABANDONED—
042Scientific and technological services, namely, research and development in the field of the manufacture of nutritional supplementsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 25, 2019MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
Mar 25, 2019ABN1ABANDONMENT - EXPRESS MAILED—
Mar 22, 2019EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Mar 20, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 20, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Mar 20, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 20, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 20, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 17, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 17, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 17, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 4, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 3, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 3, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 6, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 6, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 6, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 2, 2018DOCKASSIGNED TO EXAMINER—
Nov 2, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 27, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance